左旋多巴及左旋多巴+RO 4-4602治疗的帕金森病患者临床症状、脑脊液中高香草酸（HVA）和5-羟吲哚乙酸（5-HIAA）与血浆左旋多巴的相关性 - Suppr

Suppr

超能文献

Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.

作者信息

Campanella G, Algeri S, Cerletti C, Dolfini E, Jori A, Rinaldi F

出版信息

Eur J Clin Pharmacol. 1977 Apr 20;11(4):255-61. doi: 10.1007/BF00607673.

DOI:10.1007/BF00607673

PMID:862646

Abstract

摘要

相似文献

Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.左旋多巴及左旋多巴+RO 4-4602治疗的帕金森病患者临床症状、脑脊液中高香草酸（HVA）和5-羟吲哚乙酸（5-HIAA）与血浆左旋多巴的相关性

Eur J Clin Pharmacol. 1977 Apr 20;11(4):255-61. doi: 10.1007/BF00607673.

The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPG, HIAA and HVA levels in the cerebrospinal fluid.左旋多巴和脱羧酶抑制剂预处理的初发性帕金森病患者中，R-(-)-司来吉兰的疗效与脑脊液中抑郁以及3-甲氧基-4-羟基苯乙二醇（MHPG）、5-羟吲哚乙酸（HIAA）和高香草酸（HVA）水平相关。

Acta Neurol Scand Suppl. 1989;126:153-6. doi: 10.1111/j.1600-0404.1989.tb01795.x.

[Madopar in the treatment of paralysis agitans: II. TRH activation test, EMG examination and HVA level in cerebrospinal fluid before and after treatment].美多芭治疗震颤麻痹：II. 治疗前后的促甲状腺激素释放激素激活试验、肌电图检查及脑脊液中高香草酸水平

Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1980 Apr;13(4):223-6.

Effect of peripheral decarboxylase inhibition on HVA and 5HIAA in cerebrospinal fluid of depressed patients.外周脱羧酶抑制对抑郁症患者脑脊液中高香草酸和5-羟吲哚乙酸的影响。

Neuropsychobiology. 1975;1(1):26-31. doi: 10.1159/000117472.

Report on 45-month treatment of parkinsonism with L-dopa, alone and in association with a decarboxilase inhibitor (Ro 4-4602).

Acta Neurol Latinoam. 1974;20(1-4):116-38.

Urinary excretion of monoamines and their metabolites in patients with Parkinson's disease. Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlations.帕金森病患者单胺及其代谢产物的尿排泄情况。对单独使用左旋多巴或与多巴脱羧酶抑制剂联合进行长期治疗的反应及临床相关性。

Clin Neurol Neurosurg. 1975;78(2):77-88. doi: 10.1016/s0303-8467(75)80014-x.

Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.帕金森病与脑脊液中的胺类代谢产物：对左旋多巴治疗的启示

Eur Neurol. 1974;12(5-6):340-50. doi: 10.1159/000114631.

Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.单独使用左旋多巴或与脱羧酶抑制剂联合治疗的帕金森病患者脑脊液中的酸性单胺代谢产物。

Eur Neurol. 1973;9(6):349-62. doi: 10.1159/000114243.

Unresponsiveness to L-DOPA in parkinsonian patients: a study of homovanillic acid concentration in the cerebrospinal fluid.帕金森病患者对左旋多巴无反应：脑脊液中高香草酸浓度的研究

J Neurol Sci. 1989 Aug;92(1):65-70. doi: 10.1016/0022-510x(89)90175-5.

Madopar HBS: slow-release levodopa and benserazide in parkinsonian patients presenting marked fluctuations in symptoms on standard L-dopa treatment.美多芭缓释片：用于标准左旋多巴治疗后症状出现明显波动的帕金森病患者，含缓释左旋多巴和苄丝肼。

Eur Neurol. 1987;27 Suppl 1:68-72. doi: 10.1159/000116195.

引用本文的文献

Effect of administration of 5-hydroxytryptophan and an inhibitor of L-aromatic amino acid decarboxylase on glucose metabolism in rat brain.

Neurochem Res. 1979 Apr;4(2):277-87. doi: 10.1007/BF00964151.

本文引用的文献

L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.L-多巴：对小鼠脑内多巴胺、去甲肾上腺素和 5-羟色胺浓度的影响。

Science. 1970 May 15;168(3933):849-50. doi: 10.1126/science.168.3933.849.

A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES.一种用于儿茶酚胺分光光度荧光测定的灵敏方法。

Int J Neuropharmacol. 1964 Dec;3:643-9. doi: 10.1016/0028-3908(64)90089-9.

Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase.外周脱羧酶抑制后，3,4-二羟基苯丙氨酸引起脑内儿茶酚胺增加。

Nature. 1967 Aug 19;215(5103):852-3. doi: 10.1038/215852b0.

Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.外周脱羧酶抑制后左旋多巴的行为和生化效应。

Brain Res. 1969 Sep;15(1):233-42. doi: 10.1016/0006-8993(69)90322-9.

Critical analysis of the disability in Parkinson's disease.帕金森病残疾状况的批判性分析。

Mod Treat. 1968 Mar;5(2):257-82.

On the occurrence of homovanillic acid and 5-hydroxyindol-3-ylacetic acid in the ventricular C.S.F. of patients suffering from parkinsonism.帕金森病患者脑室脑脊液中高香草酸和5-羟吲哚-3-乙酸的出现情况。

Confin Neurol. 1967;29(2):73-7. doi: 10.1159/000103680.

Brain capillaries as a source of homovanillic acid in cerebrospinal fluid.脑毛细血管作为脑脊液中高香草酸的来源。

Brain Res. 1971 Mar 19;27(1):163-8. doi: 10.1016/0006-8993(71)90378-7.

Fluorometric determination of homovanillic acid in biological material after isolation on Sephadex G-10.在Sephadex G - 10上分离后，用荧光法测定生物材料中的高香草酸。

Anal Biochem. 1971 Mar;40(1):187-91. doi: 10.1016/0003-2697(71)90091-1.

Phenolic acid concentrations in the lumbar cerebrospinal fluid of Parkinsonian patients treated with L-dopa.接受左旋多巴治疗的帕金森病患者腰椎脑脊液中的酚酸浓度。

J Neurol Neurosurg Psychiatry. 1970 Dec;33(6):851-7. doi: 10.1136/jnnp.33.6.851.

A spectrofluorometric method for the simultaneous determination of 2-(5-hydroxyindol-3-yl) ethylamine (serotonin) and 5-hydroxyindol-3-yl-acetic acid in the brain.一种用于同时测定脑中2-(5-羟基吲哚-3-基)乙胺（血清素）和5-羟基吲哚-3-基乙酸的荧光分光光度法。

Pharmacology. 1969;2(3):171-5. doi: 10.1159/000136013.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验